These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapies for type 2 diabetes and coronary artery disease. Garratt KN; Bailey SR N Engl J Med; 2009 Oct; 361(14):1407-8; author reply 1409-10. PubMed ID: 19802916 [No Abstract] [Full Text] [Related]
4. Therapies for type 2 diabetes and coronary artery disease. Bertoldi EG; Weinert LS; Polanczyk CA N Engl J Med; 2009 Oct; 361(14):1408; author reply 1409-10. PubMed ID: 19802917 [No Abstract] [Full Text] [Related]
5. [Treatment of coronary heart disease in patients with diabetes mellitus]. Gradaus F; Leschke M; Jax TW; Schannwell CM; Schoebel FC; Strauer BE Dtsch Med Wochenschr; 1998 Nov; 123(47):1419-25. PubMed ID: 9856114 [No Abstract] [Full Text] [Related]
6. [The BARI 2D study]. Mafrici A; Briguori C G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772 [No Abstract] [Full Text] [Related]
7. [Insulin sparing and metabolic control with metformin-insulin combination]. Isnard F Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986 [No Abstract] [Full Text] [Related]
8. Therapies for type 2 diabetes and coronary artery disease. Pfisterer ME; Zellweger MJ N Engl J Med; 2009 Oct; 361(14):1407; author reply 1409-10. PubMed ID: 19797290 [No Abstract] [Full Text] [Related]
10. Diabetes control without weight gain. Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130 [No Abstract] [Full Text] [Related]
11. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease. Rutter MK; Nesto RW Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235 [TBL] [Abstract][Full Text] [Related]
12. Combination of drugs in the management of diabetes mellitus. Das S J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168 [TBL] [Abstract][Full Text] [Related]
13. [Differentiated treatment of diabetics with an acute coronary syndrome]. Hamm CW; Hamann A Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250 [No Abstract] [Full Text] [Related]
14. Meeting of the minds. Should pre-hypertension in type 2 diabetes be treated? Bihl G; Amod A; Ellis G; Moore R; Raal FJ; Gernholtz T; Schamroth C; Horak A Cardiovasc J Afr; 2010; 21(3 Suppl):S9-S13. PubMed ID: 20532426 [No Abstract] [Full Text] [Related]
15. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease]. Wiersma JJ; Trip MD; Piek JJ Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798 [TBL] [Abstract][Full Text] [Related]
16. [Incretin-mimetic drugs, an insulin alternative in type 2 diabetes]. Fabreegas B Soins; 2008 Jun; (726):34-7. PubMed ID: 18697336 [No Abstract] [Full Text] [Related]
17. The effect of pioglitazone on nitric oxide synthase in patients with type 2 diabetes mellitus. Nishio K; Shigemitsu M; Kodama Y; Itoh S; Konno N; Satoh R; Katagiri T; Kobayashi Y J Cardiometab Syndr; 2008; 3(4):200-4. PubMed ID: 19040587 [TBL] [Abstract][Full Text] [Related]
18. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Magee MF; Isley WL; Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735 [TBL] [Abstract][Full Text] [Related]
19. Follow-up of intensive glucose control in type 2 diabetes. Petrie JR N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672 [No Abstract] [Full Text] [Related]